Anti-Inflammatory Agents/adverse effects/*therapeutic use
Biomarkers/blood
C-Reactive Protein/*metabolism
Double-Blind Method
Drug Therapy, Combination
Eicosapentaenoic Acid/adverse effects/*analogs & derivatives/therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
Hypolipidemic Agents/adverse effects/*therapeutic use
Inflammation Mediators/*blood
Lipids/*blood
Metabolic Syndrome X/blood/diagnosis/*drug therapy
Time Factors
Treatment Outcome
